Archives

by in
Entry Author Date Location
We Got Deals: Financings Breathe New Life Into Local Life Sciences Companies 06/16/10 San Diego
Biogen’s CEO Retires Tomorrow, COO to Follow 06/07/10 Boston
David Berry of Flagship Ventures on Funding Advice, Investment Themes, Trends in Biofuels 05/12/10 Seattle
Oracle Acquires Phase Forward, Diax Collects Up to $12M from Paul Capital, Agios Gets $130M from Celgene, & More Boston-Area Deals News 04/21/10 Boston
Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News 04/16/10 Boston
Celgene Pumps $130M Upfront into Agios Pharma for Drugs that Starve Cancer Cells 04/15/10 Boston
Avalon Stakes Claim as Survivor Among San Diego Biotech VCs 04/12/10 San Diego
Chairman Bill Young: Next Biogen Idec CEO May Be a Scientist 02/22/10 Boston
Cell Therapeutics FDA Panel Primer: What You Need to Know to Be Ready Next Week 02/03/10 Seattle
Dendreon’s New Operations Man, Hans Bishop, Aims to Keep Provenge Trains Running on Time 01/19/10 Seattle
Acceleron Pharma Reports $10.9M Financing 12/16/09 Boston
5AM Gathers $200M Fund, Advanced Cell Technology Advances with $2.8 Million, Gloucester Picked up for $640M, & More Boston-Area Deals News 12/11/09 Boston
Acceleron Pharma Invests in Bricks & Mortar When Virtual is In Vogue 12/10/09 Boston
A Graceful Exit for Gloucester, Pink Slips at Sermo, A Half a Billion Bucks for Vertex, & More Boston-Area Life Sciences News 12/09/09 Boston
Celgene Agrees to Acquire Gloucester Pharma for $340M Cash Upfront, $300M Later 12/07/09 Boston
Acceleron, Bucking Conventional Wisdom, Pushes Ahead Drug For Bone Loss, Anemia 09/11/09 Boston
Icahn Throws Down the Gauntlet, Attacks Biogen Idec’s “Failed Leadership” 05/11/09 Boston
Genzyme Offers Glimpse at Growth Engine, New Drugs for High Cholesterol, Gaucher’s 05/07/09 Boston
Out With Hedge Funds, In With Blue Bloods: Vertex Transforms Investor Base Via Stock Sale 02/20/09 Boston
Alkermes Knocks on Door of Biotech Big Leagues, Aims to Make Drugs of its Own 02/12/09 Boston
Seattle Genetics Defies Gravity With Biotech’s First Underwritten Stock Sale in Six Months 02/05/09 Seattle
Millennium’s Velcade, As Time Wears On, Shows Durable Ability to Prolong Lives 12/08/08 Boston
Millennium CEO Dunsire Juggles Growing Pipeline, Works to Maintain Nimble Culture—as New Owner Takeda Makes the Company its Center for Cancer Drug Development 09/10/08 Boston
Page 4 of 4 « previous page

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.